Apply Now

News » Archives » October 2013

Notre Dame researchers uncover keys to antibiotic resistance in MRSA

Author: Marissa Gebhard


University of Notre Dame researchers Shahriar Mobashery and Mayland Chang and their collaborators in Spain have published research results this week that show how methicillin-resistant Staphylococcus aureus (MRSA) regulates the critical crosslinking of its cell wall in the face of beta-lactam antibiotics.

The work, published in the Proceedings of the National Academy of Sciences, reveals the mechanistic basis for how the MRSA bacterium became such a difficult pathogen over the previous 50 years, in which time it spread rapidly across the world. Read More

A new way to counter ovarian cancer’s drug resistance

Author: Angela Cavalieri

At the Harper Cancer Research Institute, Dr. Karen Cowden Dahl is leading research on ARID3B, a mysterious gene that could hold promise for identifying more aggressive forms of ovarian cancer.

Standing at a microscope in her Harper Hall laboratory, Dr. Karen Cowden Dahl is scanning through a petri dish filled with cancer cells that could represent a major step forward in ovarian cancer research. Read More

Notre Dame network physicist describes network model of brain’s connectivity

Author: Stephanie Healey

Zoltán Toroczkai

A new paper by Zoltán Toroczkai, professor of physics and concurrent professor of computer science and engineering at the University of Notre Dame, and his collaborators provides a predictive model of cerebral cortical connectivity at the interareal level. The study was published in the Oct. 2 issue of the journal Neuron.

The cerebral cortex is responsible for all the sensory, motor and cognitive functions of an individual and is arguably the most powerful known supercomputer. Read More

Research Prof. Mark Suckow: Fighting to cure prostate cancer

Author: Notre Dame News

Imagine your children, your nieces, nephews, or grandchildren losing a parent to cancer. Too many experiences and dreams are ripped away due to this terrible disease. But with new, more effective cancer treatments being developed, the prognosis for cancer patients is improving little by little. 

videopromo Read More